US-China trade war

BIO-key CEO Upbeat Despite Ongoing Trade Tensions in Q2 Update

BIO-key CEO Upbeat Despite Ongoing Trade Tensions in Q2 Update

BIO-key has issued its results for the second quarter of 2019, ended June 30th. The results reflect, to some extent, the impact of ongoing trade tensions between the US and China, alongside ongoing progress in BIO-key’s other business activities. Revenues for the quarter came in at $728,383, a slight decline (2.7 percent) against Q2 revenues…

Huawei Blacklisting Shouldn’t Affect II-VI’s Acquisition of Finisar

Huawei Blacklisting Shouldn’t Affect II-VI’s Acquisition of Finisar

US-based engineering firm II-VI is reassuring investors that its acquisition of Finisar should proceed as planned despite the US government’s placement of Huawei on its trade blacklist. The acquisition was approved by shareholders of both companies earlier this year, paving the way for a merger that could significantly extend the applications of Finisar’s 3D Sensing…

BIO-key Q1 Update Shows US-China Trade War’s Impact

BIO-key Q1 Update Shows US-China Trade War’s Impact

The escalating trade war between the US and China has made an impact on BIO-key‘s bottom line, the company’s CEO says. The comments came via the fingerprint sensor specialist’s Q1 update for 2019, in which the company saw a $289,832 year-over-year drop in revenues, which came in at $551,623, compared to $841,455 in revenues a…